Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

278 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Yellow fever disease severity and endothelial dysfunction are associated with elevated serum levels of viral NS1 protein and syndecan-1.
de Sousa FTG, Warnes CM, Manuli ER, Tjang LV, Carneiro PH, Maria de Oliveira Pinto L, Ng A, Bhat S, Zambrana JV, D'Elia Zanella LGFAB, Ho YL, Romano CM, Beatty PR, Biering SB, Kallas EG, Sabino EC, Harris E. de Sousa FTG, et al. Among authors: kallas eg. EBioMedicine. 2024 Oct 24;109:105409. doi: 10.1016/j.ebiom.2024.105409. Online ahead of print. EBioMedicine. 2024. PMID: 39454515 Free article.
Unveiling viral pathogens in acute respiratory disease: Insights from viral metagenomics in patients from the State of Alagoas, Brazil.
de Campos GM, Santos HO, Lima ARJ, Leite AB, Ribeiro G, Todão Bernardino JS, do Nascimento JPM, Souza JVC, de Lima LPO, Lima MBZ, de Araújo MA, Giovanetti M, Kallas EG, Sampaio SC, Elias MC, Slavov SN. de Campos GM, et al. Among authors: kallas eg. PLoS Negl Trop Dis. 2024 Sep 23;18(9):e0012536. doi: 10.1371/journal.pntd.0012536. eCollection 2024 Sep. PLoS Negl Trop Dis. 2024. PMID: 39312587 Free PMC article.
Efficacy and safety of Butantan-DV in participants aged 2-59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil.
Nogueira ML, Cintra MAT, Moreira JA, Patiño EG, Braga PE, Tenório JCV, de Oliveira Alves LB, Infante V, Silveira DHR, de Lacerda MVG, Pereira DB, da Fonseca AJ, Gurgel RQ, Coelho IC, Fontes CJF, Marques ETA, Romero GAS, Teixeira MM, Siqueira AM, Boaventura VS, Ramos F, Júnior EE, de Moraes JC, Whitehead SS, Esteves-Jaramillo A, Shekar T, Lee JJ, Macey J, Kelner SG, Coller BG, Boulos FC, Kallás EG; Phase 3 Butantan-DV Working Group. Nogueira ML, et al. Among authors: kallas eg. Lancet Infect Dis. 2024 Nov;24(11):1234-1244. doi: 10.1016/S1473-3099(24)00376-1. Epub 2024 Aug 5. Lancet Infect Dis. 2024. PMID: 39116904 Clinical Trial.
Duration of vaccine protection against breakthrough infections during five COVID-19 waves among healthcare workers primarily vaccinated with CoronaVac.
Luna-Muschi A, Carmo Borges I, Dos Santos Barboza A, de Faria E, Farrel Cortês M, Santos RB, Costa Silva B, Alves Maia da Silva C, Coelho Rocha E, Reis de Souza V, de Araujo Eliodoro RH, Mendes de Oliveira F, Carolina Mamana A, Miyuki Hidifira A, Nishikawara M, Bertollo Gomes Porto V, Paula B Barboza A, Sampaio V, Mariângela Simão, Lazari CS, Segurado AC, Kallas EG, Marli C Sartori A, Levin AS, Cerdeira Sabino E, Figueiredo Costa S; Covid Seq group. Luna-Muschi A, et al. Among authors: kallas eg. Vaccine. 2024 Nov 14;42(25):126114. doi: 10.1016/j.vaccine.2024.07.015. Epub 2024 Jul 16. Vaccine. 2024. PMID: 39019656
A pre-vaccination immune metabolic interplay determines the protective antibody response to a dengue virus vaccine.
Pelletier AN, Sanchez GP, Izmirly A, Watson M, Di Pucchio T, Carvalho KI, Filali-Mouhim A, Paramithiotis E, Timenetsky MDCST, Precioso AR, Kalil J, Diamond MS, Haddad EK, Kallas EG, Sekaly RP. Pelletier AN, et al. Among authors: kallas eg. Cell Rep. 2024 Jul 23;43(7):114370. doi: 10.1016/j.celrep.2024.114370. Epub 2024 Jun 18. Cell Rep. 2024. PMID: 38900640 Free PMC article.
Data-driven, cross-disciplinary collaboration: lessons learned at the largest academic health center in Latin America during the COVID-19 pandemic.
Ritto AP, de Araujo AL, de Carvalho CRR, De Souza HP, Favaretto PMES, Saboya VRB, Garcia ML, Kulikowski LD, Kallás EG, Pereira AJR, Cobello Junior V, Silva KR, Abdalla ERF, Segurado AAC, Sabino EC, Ribeiro Junior U, Francisco RPV, Miethke-Morais A, Levin ASS, Sawamura MVY, Ferreira JC, Silva CA, Mauad T, Gouveia NDC, Letaif LSH, Bego MA, Battistella LR, Duarte AJDS, Seelaender MCL, Marchini J, Forlenza OV, Rocha VG, Mendes-Correa MC, Costa SF, Cerri GG, Bonfá ESDO, Chammas R, de Barros Filho TEP, Busatto Filho G. Ritto AP, et al. Among authors: kallas eg. Front Public Health. 2024 Feb 27;12:1369129. doi: 10.3389/fpubh.2024.1369129. eCollection 2024. Front Public Health. 2024. PMID: 38476486 Free PMC article.
Immune response induced by standard and fractional doses of 17DD yellow fever vaccine.
Abdala-Torres T, Campi-Azevedo AC, da Silva-Pereira RA, Dos Santos LI, Henriques PM, Costa-Rocha IA, Otta DA, Peruhype-Magalhães V, Teixeira-Carvalho A, Araújo MSS, Fernandes EG, Sato HK, Fantinato FFST, Domingues CMAS, Kallás EG, Tomiyama HTI, Lemos JAC, Coelho-Dos-Reis JG, de Lima SMB, Schwarcz WD, de Souza Azevedo A, Trindade GF, Ano Bom APD, da Silva AMV, Fernandes CB, Camacho LAB, de Sousa Maia ML; Collaborative Group for Studies of Yellow Fever Vaccine; Martins-Filho OA, do Antonelli LRDV. Abdala-Torres T, et al. Among authors: kallas eg. NPJ Vaccines. 2024 Mar 8;9(1):54. doi: 10.1038/s41541-024-00836-w. NPJ Vaccines. 2024. PMID: 38459059 Free PMC article.
Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults.
Kallás EG, Cintra MAT, Moreira JA, Patiño EG, Braga PE, Tenório JCV, Infante V, Palacios R, de Lacerda MVG, Batista Pereira D, da Fonseca AJ, Gurgel RQ, Coelho IC, Fontes CJF, Marques ETA, Romero GAS, Teixeira MM, Siqueira AM, Barral AMP, Boaventura VS, Ramos F, Elias Júnior E, Cassio de Moraes J, Covas DT, Kalil J, Precioso AR, Whitehead SS, Esteves-Jaramillo A, Shekar T, Lee JJ, Macey J, Kelner SG, Coller BG, Boulos FC, Nogueira ML. Kallás EG, et al. N Engl J Med. 2024 Feb 1;390(5):397-408. doi: 10.1056/NEJMoa2301790. N Engl J Med. 2024. PMID: 38294972 Clinical Trial.
HIV-1 Remission: Accelerating the Path to Permanent HIV-1 Silencing.
Lyons DE, Kumar P, Roan NR, Defechereux PA, Feschotte C, Lange UC, Murthy N, Sameshima P, Verdin E, Ake JA, Parsons MS, Nath A, Gianella S, Smith DM, Kallas EG, Villa TJ, Strange R, Mwesigwa B, Furler O'Brien RL, Nixon DF, Ndhlovu LC, Valente ST, Ott M. Lyons DE, et al. Among authors: kallas eg. Viruses. 2023 Oct 28;15(11):2171. doi: 10.3390/v15112171. Viruses. 2023. PMID: 38005849 Free PMC article.
278 results